ClearRead™ CT

FDA, CE & Health Canada | Cardiothoracic | CT | Amplifier Partner

Description of use

ClearRead CT is demonstrated to improve clinical accuracy and reading time for actionable lung nodules:

  • 26% reduction in reading time (nodule search) across all studies
  • 29% reduction in missed nodules
  • Effective across all nodule types (solid, part solid, ground glass)
  • Vendor-neutral processing, supports both contract and non-contrast chest CT
  • Automated tracking and volumetric measurement of nodules over time

ClearRead CT Vessel Suppress produces a new series with non-nodular structures (particularly vascular) suppressed to improve the conspicuity of nodules, and accelerate reading in the absence of said structures. Approved for concurrent reading with original study series.
ClearRead CT Detect identifies, measures, and characterizes nodules.
ClearRead CT Compare automatically registers nodules with their presentation in a prior scan and provides volume change measurements.

The application content is provided by the respective AI vendors.